Evidence map›Paper›PMID 41981327›Full record

ArticleNature2026

Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity.

Pantelis A Nicola, Andrew R J Lawson, Alexandra Tidd, Juliette Imbert, Yoshihiro Ishida, Luke A Wylie, Paul A Scott, Kenny Roberts, Luke M R Harvey, Stefanie V Lensing and 24 more

Abstract read
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Somatic Variants in Immune Dysregulation: An Ongoing Challenge.Arthritis & rheumatology (Hoboken, N.J.) · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Pantelis A Nicola *Somatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Andrew R J Lawson *Somatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK. al28@sanger.ac.uk.ORCID http://orcid.org/0000-0003-3592-1005
Alexandra TiddSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Juliette ImbertSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Yoshihiro IshidaSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-6210-5903
Luke A WylieSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Paul A ScottSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Kenny RobertsCellular Operations, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-6155-0821
Luke M R HarveySomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Stefanie V LensingSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Wei ChengSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Federico AbascalSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-6201-1587
Daniel LeongamornlertSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-3486-3168
Yvette HooksSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Matthew MayhoSequencing Operations, Wellcome Sanger Institute, Hinxton, UK.
Nicole Müller-SienerthSequencing Operations, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-7527-5127
Sara WidaaSequencing Operations, Wellcome Sanger Institute, Hinxton, UK.
Laura MincarelliSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
James IllingCytometry Core Facility, Wellcome Sanger Institute, Hinxton, UK.
Flavia PeciCytometry Core Facility, Wellcome Sanger Institute, Hinxton, UK.
Bee Ling NgCytometry Core Facility, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-8338-4390
Georgeina L JarmanSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Andrew J C RussellBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5411-2807
Krishnaa T A MahbubaniDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-1327-2334
Kourosh Saeb-ParsyDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-0633-3696
Anna L PatersonDepartment of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Krishna ChatterjeeMedical Research Council Metabolic Diseases Unit, Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-2654-8854
Raheleh RahbariSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-1839-7785
Omer Ali BayraktarCellular Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-6055-277X
Michael R StrattonSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-6035-153X
Peter J CampbellSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
John A TadrossDepartment of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0002-8424-1252
Nadia SchoenmakersMedical Research Council Metabolic Diseases Unit, Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
Iñigo MartincorenaSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK. im3@sanger.ac.uk.ORCID http://orcid.org/0000-0003-1122-4416

Funding

Wellcome Trust
6 · The paper itself

Abstract

Our immune system contains multiple checkpoints to prevent the activation of self-reactive lymphocytes. How some lymphocytes escape these constraints to cause autoimmune disease remains poorly understood. A long-standing hypothesis posits that somatic mutations in immune regulatory genes may enable self-reactive lymphocytes to bypass tolerance checkpoints

Indexed as

AutoimmunityMutationThyroid GlandAnimalsB7-H1 AntigenB-LymphocytesFemaleHumansReceptors, Tumor Necrosis Factor, Member 14Spatial TranscriptomicsB7-H1 AntigenCD274 protein, humanReceptors, Tumor Necrosis Factor, Member 14TNFRSF14 protein, human

Identifiers

PMID41981327
PMCPMC13233322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.